Drug profile · INN
zavegepant
zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.
NMPA: clinical trials
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — zavegepant
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.70
Quick answer
zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.
Reviewed by James Park Regulatory Affairs Editor Last reviewed Jun 8, 2026
Key facts
INN zavegepant
Mechanism Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist
Target Calcitonin-gene-related peptide receptor, CALCRL/RAMP1
Mechanism of action
Calcitonin-gene-related peptide receptor, CALCRL/RAMP1 antagonist
Primary target: Calcitonin-gene-related peptide receptor, CALCRL/RAMP1
Approval history
Regional status spokes: APAC status
| Authority | Status | Date |
|---|---|---|
| NMPA | clinical trials | — |
Pipeline programs
Frequently asked questions
What is zavegepant?
zavegepant is a calcitonin-gene-related peptide receptor, calcrl/ramp1 antagonist.